Huang Chun-Hung, Shen Claire R, Li Hung, Sung Li-Yu, Wu Meng-Ying, Hu Yu-Chen
Department of Chemical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan.
Microb Cell Fact. 2016 Nov 15;15(1):196. doi: 10.1186/s12934-016-0595-3.
Cyanobacterium Synechococcus elongatus PCC 7942 holds promise for biochemical conversion, but gene deletion in PCC 7942 is time-consuming and may be lethal to cells. CRISPR interference (CRISPRi) is an emerging technology that exploits the catalytically inactive Cas9 (dCas9) and single guide RNA (sgRNA) to repress sequence-specific genes without the need of gene knockout, and is repurposed to rewire metabolic networks in various procaryotic cells.
To employ CRISPRi for the manipulation of gene network in PCC 7942, we integrated the cassettes expressing enhanced yellow fluorescent protein (EYFP), dCas9 and sgRNA targeting different regions on eyfp into the PCC 7942 chromosome. Co-expression of dCas9 and sgRNA conferred effective and stable suppression of EYFP production at efficiencies exceeding 99%, without impairing cell growth. We next integrated the dCas9 and sgRNA targeting endogenous genes essential for glycogen accumulation (glgc) and succinate conversion to fumarate (sdhA and sdhB). Transcription levels of glgc, sdhA and sdhB were effectively suppressed with efficiencies depending on the sgRNA binding site. Targeted suppression of glgc reduced the expression to 6.2%, attenuated the glycogen accumulation to 4.8% and significantly enhanced the succinate titer. Targeting sdhA or sdhB also effectively downregulated the gene expression and enhanced the succinate titer ≈12.5-fold to ≈0.58-0.63 mg/L.
These data demonstrated that CRISPRi-mediated gene suppression allowed for re-directing the cellular carbon flow, thus paving a new avenue to rationally fine-tune the metabolic pathways in PCC 7942 for the production of biotechnological products.
聚球藻属的细长聚球藻PCC 7942在生化转化方面具有潜力,但在PCC 7942中进行基因缺失耗时且可能对细胞致死。CRISPR干扰(CRISPRi)是一种新兴技术,它利用催化失活的Cas9(dCas9)和单向导RNA(sgRNA)来抑制序列特异性基因,而无需进行基因敲除,并且已被用于重新构建各种原核细胞中的代谢网络。
为了利用CRISPRi操纵PCC 7942中的基因网络,我们将表达增强型黄色荧光蛋白(EYFP)、dCas9和靶向eyfp不同区域的sgRNA的盒整合到PCC 7942染色体中。dCas9和sgRNA的共表达有效且稳定地抑制了EYFP的产生,效率超过99%,且不影响细胞生长。接下来,我们整合了靶向糖原积累(glgc)以及琥珀酸转化为富马酸(sdhA和sdhB)所必需的内源性基因的dCas9和sgRNA。glgc、sdhA和sdhB的转录水平被有效抑制,抑制效率取决于sgRNA结合位点。对glgc的靶向抑制将表达降低至6.2%,糖原积累减弱至4.8%,并显著提高了琥珀酸滴度。靶向sdhA或sdhB也有效下调了基因表达,并将琥珀酸滴度提高了约12.5倍,达到约0.58 - 0.63 mg/L。
这些数据表明,CRISPRi介导的基因抑制能够重新引导细胞碳流,从而为合理微调PCC 7942中的代谢途径以生产生物技术产品开辟了一条新途径。